Related references
Note: Only part of the references are listed.Comparison of low-normal and high-normal IGF-1 target levels during growth hormone replacement therapy: A randomized clinical trial in adult growth hormone deficiency
Christa C. van Bunderen et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Body mass index is related to microvascular vasomotion, this is partly explained by adiponectin
Michiel P. de Boer et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
Insulin-Induced Changes in Microvascular Vasomotion and Capillary Recruitment are Associated in Humans
Michiel P. de Boer et al.
MICROCIRCULATION (2014)
Does Growth Hormone Replacement Therapy Reduce Mortality in Adults with Growth Hormone Deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in Adults
Christa C. van Bunderen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control
Christian Berg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The Association of Serum Insulin-Like Growth Factor-I with Mortality, Cardiovascular Disease, and Cancer in the Elderly: A Population-Based Study
Christa C. van Bunderen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Decreased microvascular vasomotion and myogenic response in rat skeletal muscle in association with acute insulin resistance
John M. B. Newman et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Skin vasomotion investigation: A useful tool for clinical evaluation of microvascular endothelial function?
M. Rossi et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Impaired local microvascular vasodilatory effects of insulin and reduced skin microvascular vasomotion in obese women
Renate T. de Jongh et al.
MICROVASCULAR RESEARCH (2008)
Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH research society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia
Ken K. Y. Ho
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults
K. C. J. Yuen et al.
DIABETES OBESITY & METABOLISM (2007)
Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke
SP Johnsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Insulin-like growth factor-1 as a vascular protective factor
E Conti et al.
CIRCULATION (2004)
Physiological hyperinsulinaemia increases intramuscular microvascular reactive hyperaemia and vasomotion in healthy volunteers
RT de Jongh et al.
DIABETOLOGIA (2004)
Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials
P Maison et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease - A population-based case-control study
A Juul et al.
CIRCULATION (2002)
Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia
EH Serné et al.
DIABETES (2002)
Share Paper
